Anti-helminthic Drugs Industry Research Report 2025
Description
Summary
According to APO Research, the global Anti-helminthic Drugs market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Anti-helminthic Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Anti-helminthic Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Anti-helminthic Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Anti-helminthic Drugs include Anhui Shengying Pharmaceutical Co., Ltd., Beijing Taiyang Pharmaceutical Co., Ltd., Chengdu Hengda Pharmaceutical Co., Ltd., Diao Group Chengdu Pharmaceutical Co., Ltd., Fujian Dongrui Pharmaceutical Co., Ltd., Guilin Nanyao Pharmaceutical Co., Ltd., Hubei Ruihua Pharmaceutical Co., Ltd., China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. and Jiaozuo Furuitang Pharmaceutical Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Anti-helminthic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-helminthic Drugs.
The report will help the Anti-helminthic Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Anti-helminthic Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti-helminthic Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Anti-helminthic Drugs Segment by Company
Anhui Shengying Pharmaceutical Co., Ltd.
Beijing Taiyang Pharmaceutical Co., Ltd.
Chengdu Hengda Pharmaceutical Co., Ltd.
Diao Group Chengdu Pharmaceutical Co., Ltd.
Fujian Dongrui Pharmaceutical Co., Ltd.
Guilin Nanyao Pharmaceutical Co., Ltd.
Hubei Ruihua Pharmaceutical Co., Ltd.
China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd.
Jiaozuo Furuitang Pharmaceutical Co., Ltd.
Nanjing Pharmaceutical Factory Co., Ltd.
Shaanxi Hanwang Pharmaceutical Co., Ltd.
Shanghai SPH Xinyi Pharmaceutical Co., Ltd.
Shanghai Tengrui Pharmaceutical Co., Ltd.
Shaoxing Minsheng Pharmaceutical Co., Ltd.
Sichuan Tiande Pharmaceutical Co., Ltd.
Southwest Pharmaceutical Co., Ltd.
Zhejiang Anbet Pharmaceutical Co., Ltd.
Zhejiang Hisun Pharmaceutical Co., Ltd.
Anti-helminthic Drugs Segment by Type
Pyrantel Pamoate
Piperazine
Mimbendazole
Praziquantel
Albendazole
Anti-helminthic Drugs Segment by Application
For Veterinary Use
For Human Use
Anti-helminthic Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-helminthic Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anti-helminthic Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-helminthic Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Anti-helminthic Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Anti-helminthic Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Anti-helminthic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
According to APO Research, the global Anti-helminthic Drugs market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Anti-helminthic Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Anti-helminthic Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Anti-helminthic Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Anti-helminthic Drugs include Anhui Shengying Pharmaceutical Co., Ltd., Beijing Taiyang Pharmaceutical Co., Ltd., Chengdu Hengda Pharmaceutical Co., Ltd., Diao Group Chengdu Pharmaceutical Co., Ltd., Fujian Dongrui Pharmaceutical Co., Ltd., Guilin Nanyao Pharmaceutical Co., Ltd., Hubei Ruihua Pharmaceutical Co., Ltd., China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. and Jiaozuo Furuitang Pharmaceutical Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Anti-helminthic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-helminthic Drugs.
The report will help the Anti-helminthic Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Anti-helminthic Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti-helminthic Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Anti-helminthic Drugs Segment by Company
Anhui Shengying Pharmaceutical Co., Ltd.
Beijing Taiyang Pharmaceutical Co., Ltd.
Chengdu Hengda Pharmaceutical Co., Ltd.
Diao Group Chengdu Pharmaceutical Co., Ltd.
Fujian Dongrui Pharmaceutical Co., Ltd.
Guilin Nanyao Pharmaceutical Co., Ltd.
Hubei Ruihua Pharmaceutical Co., Ltd.
China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd.
Jiaozuo Furuitang Pharmaceutical Co., Ltd.
Nanjing Pharmaceutical Factory Co., Ltd.
Shaanxi Hanwang Pharmaceutical Co., Ltd.
Shanghai SPH Xinyi Pharmaceutical Co., Ltd.
Shanghai Tengrui Pharmaceutical Co., Ltd.
Shaoxing Minsheng Pharmaceutical Co., Ltd.
Sichuan Tiande Pharmaceutical Co., Ltd.
Southwest Pharmaceutical Co., Ltd.
Zhejiang Anbet Pharmaceutical Co., Ltd.
Zhejiang Hisun Pharmaceutical Co., Ltd.
Anti-helminthic Drugs Segment by Type
Pyrantel Pamoate
Piperazine
Mimbendazole
Praziquantel
Albendazole
Anti-helminthic Drugs Segment by Application
For Veterinary Use
For Human Use
Anti-helminthic Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-helminthic Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anti-helminthic Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-helminthic Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Anti-helminthic Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Anti-helminthic Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Anti-helminthic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
131 Pages
- 1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
- 2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Anti-helminthic Drugs Market Size (2020-2031)
- 2.2.2 Global Anti-helminthic Drugs Sales (2020-2031)
- 2.2.3 Global Anti-helminthic Drugs Market Average Price (2020-2031)
- 2.3 Anti-helminthic Drugs by Type
- 2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
- 2.3.2 Pyrantel Pamoate
- 2.3.3 Piperazine
- 2.3.4 Mimbendazole
- 2.3.5 Praziquantel
- 2.3.6 Albendazole
- 2.4 Anti-helminthic Drugs by Application
- 2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
- 2.4.2 For Veterinary Use
- 2.4.3 For Human Use
- 3 Market Competitive Landscape by Manufacturers
- 3.1 Global Anti-helminthic Drugs Market Competitive Situation by Manufacturers (2020 Versus 2024)
- 3.2 Global Anti-helminthic Drugs Sales (K Units) of Manufacturers (2020-2025)
- 3.3 Global Anti-helminthic Drugs Revenue of Manufacturers (2020-2025)
- 3.4 Global Anti-helminthic Drugs Average Price by Manufacturers (2020-2025)
- 3.5 Global Anti-helminthic Drugs Industry Ranking, 2023 VS 2024 VS 2025
- 3.6 Global Manufacturers of Anti-helminthic Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Anti-helminthic Drugs, Product Type & Application
- 3.8 Global Manufacturers of Anti-helminthic Drugs, Established Date
- 3.9 Global Anti-helminthic Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
- 4 Manufacturers Profiled
- 4.1 Anhui Shengying Pharmaceutical Co., Ltd.
- 4.1.1 Anhui Shengying Pharmaceutical Co., Ltd. Company Information
- 4.1.2 Anhui Shengying Pharmaceutical Co., Ltd. Business Overview
- 4.1.3 Anhui Shengying Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.1.4 Anhui Shengying Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
- 4.1.5 Anhui Shengying Pharmaceutical Co., Ltd. Recent Developments
- 4.2 Beijing Taiyang Pharmaceutical Co., Ltd.
- 4.2.1 Beijing Taiyang Pharmaceutical Co., Ltd. Company Information
- 4.2.2 Beijing Taiyang Pharmaceutical Co., Ltd. Business Overview
- 4.2.3 Beijing Taiyang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.2.4 Beijing Taiyang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
- 4.2.5 Beijing Taiyang Pharmaceutical Co., Ltd. Recent Developments
- 4.3 Chengdu Hengda Pharmaceutical Co., Ltd.
- 4.3.1 Chengdu Hengda Pharmaceutical Co., Ltd. Company Information
- 4.3.2 Chengdu Hengda Pharmaceutical Co., Ltd. Business Overview
- 4.3.3 Chengdu Hengda Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.3.4 Chengdu Hengda Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
- 4.3.5 Chengdu Hengda Pharmaceutical Co., Ltd. Recent Developments
- 4.4 Diao Group Chengdu Pharmaceutical Co., Ltd.
- 4.4.1 Diao Group Chengdu Pharmaceutical Co., Ltd. Company Information
- 4.4.2 Diao Group Chengdu Pharmaceutical Co., Ltd. Business Overview
- 4.4.3 Diao Group Chengdu Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.4.4 Diao Group Chengdu Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
- 4.4.5 Diao Group Chengdu Pharmaceutical Co., Ltd. Recent Developments
- 4.5 Fujian Dongrui Pharmaceutical Co., Ltd.
- 4.5.1 Fujian Dongrui Pharmaceutical Co., Ltd. Company Information
- 4.5.2 Fujian Dongrui Pharmaceutical Co., Ltd. Business Overview
- 4.5.3 Fujian Dongrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.5.4 Fujian Dongrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
- 4.5.5 Fujian Dongrui Pharmaceutical Co., Ltd. Recent Developments
- 4.6 Guilin Nanyao Pharmaceutical Co., Ltd.
- 4.6.1 Guilin Nanyao Pharmaceutical Co., Ltd. Company Information
- 4.6.2 Guilin Nanyao Pharmaceutical Co., Ltd. Business Overview
- 4.6.3 Guilin Nanyao Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.6.4 Guilin Nanyao Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
- 4.6.5 Guilin Nanyao Pharmaceutical Co., Ltd. Recent Developments
- 4.7 Hubei Ruihua Pharmaceutical Co., Ltd.
- 4.7.1 Hubei Ruihua Pharmaceutical Co., Ltd. Company Information
- 4.7.2 Hubei Ruihua Pharmaceutical Co., Ltd. Business Overview
- 4.7.3 Hubei Ruihua Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.7.4 Hubei Ruihua Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
- 4.7.5 Hubei Ruihua Pharmaceutical Co., Ltd. Recent Developments
- 4.8 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd.
- 4.8.1 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Company Information
- 4.8.2 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Business Overview
- 4.8.3 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.8.4 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
- 4.8.5 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Recent Developments
- 4.9 Jiaozuo Furuitang Pharmaceutical Co., Ltd.
- 4.9.1 Jiaozuo Furuitang Pharmaceutical Co., Ltd. Company Information
- 4.9.2 Jiaozuo Furuitang Pharmaceutical Co., Ltd. Business Overview
- 4.9.3 Jiaozuo Furuitang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.9.4 Jiaozuo Furuitang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
- 4.9.5 Jiaozuo Furuitang Pharmaceutical Co., Ltd. Recent Developments
- 4.10 Nanjing Pharmaceutical Factory Co., Ltd.
- 4.10.1 Nanjing Pharmaceutical Factory Co., Ltd. Company Information
- 4.10.2 Nanjing Pharmaceutical Factory Co., Ltd. Business Overview
- 4.10.3 Nanjing Pharmaceutical Factory Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.10.4 Nanjing Pharmaceutical Factory Co., Ltd. Anti-helminthic Drugs Product Portfolio
- 4.10.5 Nanjing Pharmaceutical Factory Co., Ltd. Recent Developments
- 4.11 Shaanxi Hanwang Pharmaceutical Co., Ltd.
- 4.11.1 Shaanxi Hanwang Pharmaceutical Co., Ltd. Company Information
- 4.11.2 Shaanxi Hanwang Pharmaceutical Co., Ltd. Business Overview
- 4.11.3 Shaanxi Hanwang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.11.4 Shaanxi Hanwang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
- 4.11.5 Shaanxi Hanwang Pharmaceutical Co., Ltd. Recent Developments
- 4.12 Shanghai SPH Xinyi Pharmaceutical Co., Ltd.
- 4.12.1 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Company Information
- 4.12.2 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Business Overview
- 4.12.3 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.12.4 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
- 4.12.5 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Recent Developments
- 4.13 Shanghai Tengrui Pharmaceutical Co., Ltd.
- 4.13.1 Shanghai Tengrui Pharmaceutical Co., Ltd. Company Information
- 4.13.2 Shanghai Tengrui Pharmaceutical Co., Ltd. Business Overview
- 4.13.3 Shanghai Tengrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.13.4 Shanghai Tengrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
- 4.13.5 Shanghai Tengrui Pharmaceutical Co., Ltd. Recent Developments
- 4.14 Shaoxing Minsheng Pharmaceutical Co., Ltd.
- 4.14.1 Shaoxing Minsheng Pharmaceutical Co., Ltd. Company Information
- 4.14.2 Shaoxing Minsheng Pharmaceutical Co., Ltd. Business Overview
- 4.14.3 Shaoxing Minsheng Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.14.4 Shaoxing Minsheng Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
- 4.14.5 Shaoxing Minsheng Pharmaceutical Co., Ltd. Recent Developments
- 4.15 Sichuan Tiande Pharmaceutical Co., Ltd.
- 4.15.1 Sichuan Tiande Pharmaceutical Co., Ltd. Company Information
- 4.15.2 Sichuan Tiande Pharmaceutical Co., Ltd. Business Overview
- 4.15.3 Sichuan Tiande Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.15.4 Sichuan Tiande Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
- 4.15.5 Sichuan Tiande Pharmaceutical Co., Ltd. Recent Developments
- 4.16 Southwest Pharmaceutical Co., Ltd.
- 4.16.1 Southwest Pharmaceutical Co., Ltd. Company Information
- 4.16.2 Southwest Pharmaceutical Co., Ltd. Business Overview
- 4.16.3 Southwest Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.16.4 Southwest Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
- 4.16.5 Southwest Pharmaceutical Co., Ltd. Recent Developments
- 4.17 Zhejiang Anbet Pharmaceutical Co., Ltd.
- 4.17.1 Zhejiang Anbet Pharmaceutical Co., Ltd. Company Information
- 4.17.2 Zhejiang Anbet Pharmaceutical Co., Ltd. Business Overview
- 4.17.3 Zhejiang Anbet Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.17.4 Zhejiang Anbet Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
- 4.17.5 Zhejiang Anbet Pharmaceutical Co., Ltd. Recent Developments
- 4.18 Zhejiang Hisun Pharmaceutical Co., Ltd.
- 4.18.1 Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information
- 4.18.2 Zhejiang Hisun Pharmaceutical Co., Ltd. Business Overview
- 4.18.3 Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.18.4 Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
- 4.18.5 Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Developments
- 5 Global Anti-helminthic Drugs Market Scenario by Region
- 5.1 Global Anti-helminthic Drugs Market Size by Region: 2020 VS 2024 VS 2031
- 5.2 Global Anti-helminthic Drugs Sales by Region: 2020-2031
- 5.2.1 Global Anti-helminthic Drugs Sales by Region: 2020-2025
- 5.2.2 Global Anti-helminthic Drugs Sales by Region: 2026-2031
- 5.3 Global Anti-helminthic Drugs Revenue by Region: 2020-2031
- 5.3.1 Global Anti-helminthic Drugs Revenue by Region: 2020-2025
- 5.3.2 Global Anti-helminthic Drugs Revenue by Region: 2026-2031
- 5.4 North America Anti-helminthic Drugs Market Facts & Figures by Country
- 5.4.1 North America Anti-helminthic Drugs Market Size by Country: 2020 VS 2024 VS 2031
- 5.4.2 North America Anti-helminthic Drugs Sales by Country (2020-2031)
- 5.4.3 North America Anti-helminthic Drugs Revenue by Country (2020-2031)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Anti-helminthic Drugs Market Facts & Figures by Country
- 5.5.1 Europe Anti-helminthic Drugs Market Size by Country: 2020 VS 2024 VS 2031
- 5.5.2 Europe Anti-helminthic Drugs Sales by Country (2020-2031)
- 5.5.3 Europe Anti-helminthic Drugs Revenue by Country (2020-2031)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Anti-helminthic Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Anti-helminthic Drugs Market Size by Country: 2020 VS 2024 VS 2031
- 5.6.2 Asia Pacific Anti-helminthic Drugs Sales by Country (2020-2031)
- 5.6.3 Asia Pacific Anti-helminthic Drugs Revenue by Country (2020-2031)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Anti-helminthic Drugs Market Facts & Figures by Country
- 5.7.1 South America Anti-helminthic Drugs Market Size by Country: 2020 VS 2024 VS 2031
- 5.7.2 South America Anti-helminthic Drugs Sales by Country (2020-2031)
- 5.7.3 South America Anti-helminthic Drugs Revenue by Country (2020-2031)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Anti-helminthic Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Anti-helminthic Drugs Market Size by Country: 2020 VS 2024 VS 2031
- 5.8.2 Middle East and Africa Anti-helminthic Drugs Sales by Country (2020-2031)
- 5.8.3 Middle East and Africa Anti-helminthic Drugs Revenue by Country (2020-2031)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
- 6 Segment by Type
- 6.1 Global Anti-helminthic Drugs Sales by Type (2020-2031)
- 6.1.1 Global Anti-helminthic Drugs Sales by Type (2020-2031) & (K Units)
- 6.1.2 Global Anti-helminthic Drugs Sales Market Share by Type (2020-2031)
- 6.2 Global Anti-helminthic Drugs Revenue by Type (2020-2031)
- 6.2.1 Global Anti-helminthic Drugs Sales by Type (2020-2031) & (US$ Million)
- 6.2.2 Global Anti-helminthic Drugs Revenue Market Share by Type (2020-2031)
- 6.3 Global Anti-helminthic Drugs Price by Type (2020-2031)
- 7 Segment by Application
- 7.1 Global Anti-helminthic Drugs Sales by Application (2020-2031)
- 7.1.1 Global Anti-helminthic Drugs Sales by Application (2020-2031) & (K Units)
- 7.1.2 Global Anti-helminthic Drugs Sales Market Share by Application (2020-2031)
- 7.2 Global Anti-helminthic Drugs Revenue by Application (2020-2031)
- 7.2.1 Global Anti-helminthic Drugs Sales by Application (2020-2031) & (US$ Million)
- 7.2.2 Global Anti-helminthic Drugs Revenue Market Share by Application (2020-2031)
- 7.3 Global Anti-helminthic Drugs Price by Application (2020-2031)
- 8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Anti-helminthic Drugs Value Chain Analysis
- 8.1.1 Anti-helminthic Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Anti-helminthic Drugs Production Mode & Process
- 8.2 Anti-helminthic Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Anti-helminthic Drugs Distributors
- 8.2.3 Anti-helminthic Drugs Customers
- 9 Global Anti-helminthic Drugs Analyzing Market Dynamics
- 9.1 Anti-helminthic Drugs Industry Trends
- 9.2 Anti-helminthic Drugs Industry Drivers
- 9.3 Anti-helminthic Drugs Industry Opportunities and Challenges
- 9.4 Anti-helminthic Drugs Industry Restraints
- 10 Report Conclusion
- 11 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
